Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine

Psychiatria Danubina

Volumn 22, Issue 1, 2010, Pages 85-89

  Herceg, Miroslav ^a   Mužinić, Lana ^a   Jukić, Vlado ^a  

^a Psychiatric Hospital Vrap e   (Croatia)

Author keywords

Blood dyscrasia; Clozapine; Epileptic seizures; Leucopenia; Thrombocytopenia

Indexed keywords

CLOZAPINE; GRANULOCYTE COLONY STIMULATING FACTOR; LITHIUM; METHYLPHENOBARBITAL; ANTICONVULSIVE AGENT; LITHIUM CARBONATE; NEUROLEPTIC AGENT; TRANQUILIZER;

AGRANULOCYTOSIS; ANEMIA; BLOOD DYSCRASIA; CONFERENCE PAPER; ELECTROENCEPHALOGRAM; EOSINOPHILIA; HUMAN; LEUKOCYTOSIS; LEUKOPENIA; NEUTROPENIA; RELAPSE; SCHIZOPHRENIA; SEIZURE; THROMBOCYTHEMIA; THROMBOCYTOPENIA; ADULT; BLOOD; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG COMBINATION; EPILEPSY; FEMALE; PSYCHOLOGICAL ASPECT; PSYCHOSIS; RECURRENT DISEASE; REVIEW; RISK FACTOR; WITHDRAWAL SYNDROME;

ADULT; AGRANULOCYTOSIS; ANTICONVULSANTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; LEUKOPENIA; LITHIUM CARBONATE; PSYCHOTIC DISORDERS; RECURRENCE; RISK FACTORS; SCHIZOPHRENIA; SUBSTANCE WITHDRAWAL SYNDROME; THROMBOCYTOPENIA;

EID: 77957666450     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Ahokas A, Elonen E. Circadian rhythm of white blood cells during clozapine treatment. Psychopharmacology 1999;144:301-2. (Pubitemid 29307284)
2. Bender S, Linka T, Wolstein J at al. Safety and efficacy of combined clozapine-lithium pharmacotherapy. International Journal of Neuropsychopharmacology 2004;7:59-63. (Pubitemid 38523808)
3. Bertillson L, Carrillo JA, Dahl ML, and al. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. British Journal of Clinical Pharmacology 1994. 38;471-473.
4. Blier P, Slater S, Measham T et al. Lithium and clozapine-induced neutropenia/agranulocytosis. Int Clin Psychopharmacol 1998;13:137-140. (Pubitemid 28318354)
5. Costa-Campos L, Iwu M, Elisabetsky E. Lack of proconvulsant activity of the antipsychotic alkaloid alstonine. J Ethnopharmacol. 2004;93:307-10. (Pubitemid 38962421)
6. Devinsky O, Honigfeld G, Patin J. Clozapine-related seizures. Neurology. 1991;41:369-71.
7. Devinsky O, Pacia SV. Seizures during clozapine therapy. Journal of Clinical Psychiatry 1994; 55: 153-156. (Pubitemid 24353042)
8. Durst R, Dorevitch A, Fraenkel Y. Platelet dysfunction associated with clozapine therapy. South Med J 1993;86:1170-2. (Pubitemid 23319032)
9. Gonzales MF, Elmore J, Luebbert C. Evidence for immune etiology in clozapine-induced thrombocytopenia of 40 months' duration: a case report.
10. Greenwood-Smith C, Lubman, D, Castle, DJ. Serum clozapine levels: a review of their clinical utility. Journal of Psychopharmacology 2003; 17:234-238. (Pubitemid 36753542)
11. Hagg S, Rosenius S, Spigest O. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis. Int Clin Psychopharmacol 2003;18:173-174. (Pubitemid 36571063)
12. Hagg S, Spigest O, Soderstrom TG. Association of venous thromboembolism and clozapine. Lancet 2000;355:1155-6. (Pubitemid 30172939)
13. Hampson ME. Clozapine-induced thrombocytosis. Br J Psychiatry. 2000;177:372-3.
14. Henderson DC, Cagliero E, Gray C at al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 2000; 157:975-81. (Pubitemid 30412350)
15. Hummer M, Kurz M, Barnas C, et al. Clozapine-induced transient white blood count disoreders. J Clin Psychiatry 1994;55:429-32.
16. Kanaan RA, Kerwin R. Lithium and clozapine rechallange: a retrospective case analysis. J Clin Psychiatry 2006;67:756-760. (Pubitemid 43946182)
17. Killian JG, Kerr K, Lawrence C at al. Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999;354:1841-5.
18. Kramlinger KG, Post RM. Addition of lithium carbonate to carbamazepine. Hematological and thyroid effects. Am J Psychiatry 1990;147:615-20. (Pubitemid 20153433)
19. Lambertenghi Deliliers G. Blood dyscrasias in clozapine-treated patients in Italy. Haematologica. 2000;85:233-7. (Pubitemid 30340137)
20. McEvoy JP, Lieberman JA, Scott Stroup T, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry 2006; 163: 600-610. (Pubitemid 44464569)
21. Mihaljević-Peleš A, Jakovljević M, Mrsić M, Šagud M. Trombocytopenia associated with clozapine and fluphenazine. Nord J Psychiatry 2001;55:449-50.
22. Miller DD. Review and management of clozapine side effects. J Clin Psychiatry 2000;61:14-7.
23. Naber D. Optimizing clozapine treatment. J Clin Psychiatry.1999;60:35-8. (Pubitemid 29283181)
24. Pacia SV, Devinsky O.(1994) Clozapine-related seizures: experience with 5629 patients. Neurology 1994; 44: 2247-2249. (Pubitemid 24382717)
25. Papadaki HA, Eliopoluos GD. An overview on the diagnosis, classification and differential diagnosis of chronic neutropenias. Haema 2002;5:39-49.
26. Pirmohamed M, Park K. Mechanism of clozapine-iduced agranulocytosis. CNS Drugs 1997;7:139-58.
27. Rudolf J, Grond M, Neveling M, Heiss WD. Clozapine-induced agranulocytosis and thrombopenia in patient with dopaminergic psychosis. J Neural Transm. 1997;104:1305-11. (Pubitemid 28031824)
28. Sajatovic, M, Meltzer, HY. Clozapine-induced myoclonus and generalized seizures. Biological Psychiatry 1994; 39: 367-370. (Pubitemid 26122563)
29. Silvestri, RC, Bromfield, EB, Khoshbin, S. Clozapine-induced seizures and EEG abnormalities in ambulatory psychiatric patients. Annals of Pharmacotherapy 1998; 32: 1147-1151. (Pubitemid 28543458)
30. Small JG, Klapper MH, Malloy FW et al. Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizaoaffective disorder. J Clin Psychopharmacol 2003; 23:223-8. (Pubitemid 36807788)
31. Sparshatt A, Taylor D. Valproate as prophylaxis for clozapine-induced seizures: survey of practice. Psychiatruc Bulletin 2008;32:262-265. (Pubitemid 351943659)
32. Stein RS, Hanson G, Koethe S et al. Lithium-induced granulocytosis. Ann Intern Med 1978;88:809-10. (Pubitemid 8351392)
33. Taner, E, Cosar, B, Isik, E. Clozapine-induced myoclonic seizures and valproic acid. International Journal of Psychiatry in Clinical Practice1998; 2: 53-55. (Pubitemid 28168377)
34. Taylor DM, McAskill R. Atypical antipsychotics and weight gain: a systematic review. Acta Psychiatr Scand 2000; 101:416-32. (Pubitemid 30365564)
35. Taylor, DM, Duncan-McConnell, D. Refractory schizophrenia and atypical antipsychotics. Journal of Psychopharmacology 2000; 14: 409-418. (Pubitemid 32059788)
36. Toth P, Frankenburg FR. Clozapine and seizures: a review. Can J Psychiatry. 1994;39:236-8. (Pubitemid 24188787)
37. Usiskin SI, Nicolson R, Lenane M, Rapoport JL. Gabapentin prophylaxis of clozapine-induced seizures. Am J Psychiatry. 2000;157:482-3.
38. Valevski A, Modai I, Lahav M et al. Clozapine-lithium combined treatment and agranulocytosis. Int Clin Psychopharmacol 1993;8:63-65. (Pubitemid 23096509)
39. Welch, J, Manschreck, T, Redmond, D. Clozapine-induced seizures and EEG changes. Journal of Neuropsychiatry and Clinical Neurosciences 1994; 6: 250-256. (Pubitemid 24239741)
40. Whiskey E, Taylor D. Restarting clozapine after neutropenia, evaluating the possibilities and practicalities. CNS Drugs 2007;21:25-35. (Pubitemid 46072348)
41. Wilson WH, Claussen AM. Seizures associated with clozapine treatment in a state hospital. J Clin Psychiatry. 1994;55:184-8. (Pubitemid 24184826)
42. Young CR, Bowers MB, Mazure CM. Management of the adverse effects of clozapine. Schizophr Bull. 1998; 24:381-90. (Pubitemid 28378223)